CY1105285T1 - Διepγασια για τον καθαρισμο βακτηριακα εκφραζομενων πρωτεϊνων - Google Patents

Διepγασια για τον καθαρισμο βακτηριακα εκφραζομενων πρωτεϊνων

Info

Publication number
CY1105285T1
CY1105285T1 CY20061100623T CY061100623T CY1105285T1 CY 1105285 T1 CY1105285 T1 CY 1105285T1 CY 20061100623 T CY20061100623 T CY 20061100623T CY 061100623 T CY061100623 T CY 061100623T CY 1105285 T1 CY1105285 T1 CY 1105285T1
Authority
CY
Cyprus
Prior art keywords
purification
diagesia
expressed proteins
bacterially expressed
degradation
Prior art date
Application number
CY20061100623T
Other languages
English (en)
Inventor
Luciano Capponi
Mara Rossi
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of CY1105285T1 publication Critical patent/CY1105285T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η αίτηση ευρεσιτεχνίας σχετίζεται με διεργασία για τον καθαρισμό πρωτεϊνών εκφραζόμενων εντός προκαρυωτικών κυττάρων, η οποία περιλαμβάνει παρεμβολή κάποιου σταδίου χρωματογραφίας ανάστροφης φάσης μεταξύ των σταδίων εξαγωγής/αποδιάταξης και αναδιάταξης.
CY20061100623T 2004-01-19 2006-05-15 Διepγασια για τον καθαρισμο βακτηριακα εκφραζομενων πρωτεϊνων CY1105285T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/050025 WO2005068500A1 (en) 2004-01-19 2004-01-19 Process for the purification of bacterially expressed proteins

Publications (1)

Publication Number Publication Date
CY1105285T1 true CY1105285T1 (el) 2010-03-03

Family

ID=37055134

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100623T CY1105285T1 (el) 2004-01-19 2006-05-15 Διepγασια για τον καθαρισμο βακτηριακα εκφραζομενων πρωτεϊνων

Country Status (14)

Country Link
EP (1) EP1439191B1 (el)
JP (1) JP4865569B2 (el)
AT (1) ATE322506T1 (el)
AU (1) AU2004313698B2 (el)
CA (1) CA2552790C (el)
CY (1) CY1105285T1 (el)
DE (1) DE60304435T2 (el)
DK (1) DK1439191T3 (el)
ES (1) ES2257642T3 (el)
IL (1) IL176763A (el)
NO (1) NO20063280L (el)
PT (1) PT1439191E (el)
SI (1) SI1439191T1 (el)
WO (1) WO2005068500A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1439191T1 (sl) * 2004-01-19 2006-06-30 Ares Trading Sa Postopek ciscenja proteinov izrazenih v bakteriji
WO2005077973A1 (en) * 2004-02-11 2005-08-25 Virchow Biotech Private Limited Purification of recombinant human proteins
WO2010050485A1 (ja) * 2008-10-28 2010-05-06 学校法人関西学院 リフォールディング剤および蛋白質のリフォールディング方法
KR20240064367A (ko) * 2022-11-04 2024-05-13 주식회사 대웅제약 TGF-β3 단백질의 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912327A (en) * 1996-09-30 1999-06-15 Human Genome Sciences, Inc. Method of purifying chemokines from inclusion bodies
AU771437B2 (en) * 1998-07-06 2004-03-25 Scion Pharmaceuticals, Inc. Methods for treating neurological injuries and disorders
GB0006537D0 (en) * 2000-03-17 2000-05-10 Angeletti P Ist Richerche Bio Assays and screening methods
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
DE60231057D1 (de) * 2001-12-17 2009-03-19 Serono Lab Chemokine mutanten, die als chemokine antagonisten wirken
SI21102A (sl) * 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
JP2006502980A (ja) * 2002-06-25 2006-01-26 ファルマシア・コーポレーション アリールスルホニルヒドロキサム酸およびアミド誘導体、ならびにプロテアーゼ阻害薬としてのそれらの使用
SI1439191T1 (sl) * 2004-01-19 2006-06-30 Ares Trading Sa Postopek ciscenja proteinov izrazenih v bakteriji

Also Published As

Publication number Publication date
IL176763A (en) 2011-02-28
NO20063280L (no) 2006-10-16
AU2004313698A1 (en) 2005-07-28
EP1439191B1 (en) 2006-04-05
JP2007537150A (ja) 2007-12-20
SI1439191T1 (sl) 2006-06-30
DK1439191T3 (da) 2006-08-14
JP4865569B2 (ja) 2012-02-01
CA2552790C (en) 2011-08-16
IL176763A0 (en) 2006-10-31
EP1439191A1 (en) 2004-07-21
WO2005068500A1 (en) 2005-07-28
ATE322506T1 (de) 2006-04-15
ES2257642T3 (es) 2006-08-01
DE60304435D1 (de) 2006-05-18
PT1439191E (pt) 2006-06-30
DE60304435T2 (de) 2006-08-24
AU2004313698B2 (en) 2010-04-01
CA2552790A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
NL1026467A1 (nl) Composiet semipermeabel membraan, alsmede productiewerkwijze daarvoor.
CY1121580T1 (el) ΝΕΟΙ ΠΡΟΑΓΩΓΕΙΣ β-ΑΚΤΙΝΗΣ ΚΑΙ RPS21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
EA200702210A1 (ru) Способ очистки белков
DK2092064T3 (da) Fremgangsmåde til forberedende RNA-oprensning ved hjælp af HPLC
DE602004016441D1 (de) Hilfsystem für ein Gaspedal
DE112004000372D2 (de) Destillationsverfahren
WO2003102132A3 (en) Non-affinity purification of proteins
ITTV20030095A1 (it) Calzatura con sottopiede composito.
EA200702643A1 (ru) Антитела, связывающие tweak
DK1940918T3 (da) Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme
DK1722834T3 (da) Matrix, som omfatter naturligt forekommende tværbundet proteinskelet
DE60217708D1 (de) Verfahren, um ein elastisches verbundmaterial herzustellen
BR112012008173A2 (pt) molécula de ligação específica de rsv
DK1835816T3 (da) Fremgangsmåde til produktion af proteinhydrolysater
DK1833965T3 (da) Fremgangsmåde til visning af ribosom eller mrna med udvælgelse for øget stabilitet for proteinet
DE602004018095D1 (de) Redundanter Resolver mit veränderlicher Reluktanz
BRPI0417992A (pt) método para purificar fsh
CY1105285T1 (el) Διepγασια για τον καθαρισμο βακτηριακα εκφραζομενων πρωτεϊνων
BR0308000B1 (pt) processo de separaÇço de alceno.
MX294935B (es) Regeneracion de fases estacionarias cromatograficas.
DK1578442T3 (da) Fremgangsmåde til isolering af endotoxiner
ITIM20030011A1 (it) Particolare vetro per orologio, che permette
DK1695085T3 (da) Fremgangsmåde til påvisning af endotoksin
ITMI20041920A1 (it) Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina